Nerve modulation systems

US9724107B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9724107-B2
Application numberUS-201615241528-A
CountryUS
Kind codeB2
Filing dateAug 19, 2016
Priority dateSep 26, 2008
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

System and methods for channeling a path into bone include a trocar having a proximal end, distal end and a central channel disposed along a central axis of the trocar. The trocar includes a distal opening at the distal end of the trocar. The system includes a curved cannula sized to be received in the central channel, the curved cannula comprising a curved distal end configured to be extended outward from the distal opening to generate a curved path extending away from the trocar. The curved cannula has a central passageway having a diameter configured to allow a treatment device to be delivered through the central passageway to a location beyond the curved path.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for accessing and treating a target treatment site within bone, the system comprising: an elongate shaft having a proximal end and a distal end, wherein the proximal end comprises a handle, wherein the elongate shaft comprises a central lumen extending from the proximal end to the distal end; a cannula; a first stylet; a second stylet; and a radiofrequency (“RF”) energy delivery device configured to deliver energy to the target treatment site, wherein the cannula comprises an internal passageway and a first alignment member at a proximal portion of the cannula, wherein the first stylet is sized such that at least a distal tip of the first stylet extends beyond an opening at a distal end of the cannula, wherein the cannula and the first stylet are together configured to be introduced through the central lumen of the elongate shaft, wherein the distal tip of the first stylet is configured to form a first path toward the target treatment site within a cancellous region of the bone as at least the distal tip of the first stylet is advanced beyond the distal end of the elongate shaft, wherein the second stylet is configured to be inserted within the internal passageway of the cannula upon removal of the first stylet, wherein a distal tip of the second stylet is configured to be advanced beyond the opening at the distal end of the cannula to form a second path beyond the first path, wherein the RF energy delivery device is configured to be inserted within the internal passageway of the cannula upon removal of the second stylet and advanced until at least a distal end portion of the RF energy delivery device is beyond the opening at the distal end of the cannula and positioned along the second path, and wherein the RF energy delivery device is configured to heat the target treatment site sufficient to denervate a nerve within the bone. 2. The system of claim 1 , wherein the RF energy delivery device is configured to heat the target treatment site sufficient to ablate the nerve. 3. The system of claim 1 , wherein the RF energy delivery device is configured to heat the target treatment site sufficient to denervate the nerve without necrosis of tissue. 4. The system of claim 1 , wherein the RF energy delivery device comprises a bipolar electrode assembly. 5. The system of claim 4 , wherein the bipolar electrode assembly comprises a tip electrode and a second electrode spaced apart from the tip electrode. 6. The system of claim 1 , wherein the first stylet comprises a second alignment member configured to be aligned with the first alignment member of the cannula so as to facilitate proper alignment of the cannula and the first stylet. 7. The system of claim 1 , wherein the cannula comprises a deflectable tip with a preformed curve. 8. The system of claim 1 , wherein the cannula comprises a Nitinol tube. 9. A system for accessing and treating a target treatment location within bone, the system comprising: an elongate shaft having a proximal end and a distal end, wherein the elongate shaft comprises a central lumen extending from the proximal end to the distal end; a cannula having an internal passageway and an opening at a distal end of the cannula; a first stylet sized to be advanced through the internal passageway of the cannula until a distal tip of the first stylet extends to or beyond the opening at the distal end of the cannula, thereby facilitating formation of a first path within the bone as the cannula and the first stylet are advanced through and beyond the central lumen of the elongate shaft toward the target treatment location within the bone; a second stylet sized to be advanced through the internal passageway of the cannula until a distal tip of the second stylet extends beyond the opening at the distal end of the cannula to form a second path beyond the first path within the bone; an energy delivery device configured to deliver energy to heat the target treatment location; wherein, after removal of the second stylet, the energy delivery device is sized and configured to be advanced through the internal passageway of the cannula and out of the opening at the distal end of the cannula to a position along the second path, and wherein the energy is configured to heat the target treatment location sufficient to denervate a nerve at the target treatment location. 10. The system of claim 9 , wherein the energy is configured to heat the target treatment location sufficient to ablate the nerve. 11. The system of claim 9 , wherein the energy is configured to heat the target treatment location sufficient to denervate the nerve without necrosis of tissue. 12. The system of claim 9 , wherein the energy delivery device comprises a bipolar radiofrequency probe comprising a first tip electrode and a second electrode spaced apart from the first tip electrode. 13. The system of claim 9 , wherein the energy delivery device comprises an ultrasound energy delivery device. 14. The system of claim 9 , wherein the opening at the distal end of the cannula comprises an axial opening. 15. A system for accessing and treating a target region within bone, the system comprising: an elongate shaft having a proximal end and a distal end, wherein the elongate shaft comprises a central lumen extending from the proximal end to the distal end; a cannula, wherein the cannula comprises an internal passageway; a first stylet, wherein the first stylet is configured for insertion into and through the internal passageway of the cannula such that a distal tip of the first stylet extends beyond an opening at a distal end of the cannula, wherein the cannula and the first stylet are configured to together form a first channel toward the target region within the bone; a second stylet configured to be inserted within the internal passageway of the cannula after removal of the first stylet from the cannula and sized to be advanced through the internal passageway of the cannula until a distal tip of the second stylet extends beyond the opening at the distal end of the cannula to form a second channel beyond the first channel within the bone; and a treatment device sized and configured to be delivered through the internal passageway of the cannula and advanced out of the opening at the distal end of the cannula to a position along the second channel within the bone. 16. The system of claim 15 , wherein the treatment device comprises a flexible bipolar radiofrequency energy delivery device having two electrodes configured to deliver energy to the target region, wherein the radiofrequency energy delivery device is configured to be inserted through the internal passageway of the cannula upon removal of the second stylet, and wherein the energy is configured to heat the target region sufficient to ablate an intraosseous nerve within the target region. 17. The system of claim 15 , wherein the treatment device is selected from the group consisting of: a monopolar radiofrequency energy delivery device, a tripolar radiofrequency energy delivery device, an ultrasound device, a radiation device, a steam device, a microwave energy delivery device, a fluid delivery device, and a laser device. 18. The system of claim 15 , wherein the cannula comprises a first alignment member at a proximal portion of the cannula and wherein the first stylet comprises a second alignment member configured to be aligned with the first alignment member of the cannula to facilitate proper alignment of the cannula and the first stylet. 19. The syst

Assignees

Inventors

Classifications

  • Access ports, e.g. toroid shape introducers for instruments or hands (access sites for liquids A61M39/0247) · CPC title

  • Generators therefor · CPC title

  • for producing a curved bore · CPC title

  • Spine, e.g. intervertebral disc · CPC title

  • Cables or rods · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9724107B2 cover?
System and methods for channeling a path into bone include a trocar having a proximal end, distal end and a central channel disposed along a central axis of the trocar. The trocar includes a distal opening at the distal end of the trocar. The system includes a curved cannula sized to be received in the central channel, the curved cannula comprising a curved distal end configured to be extended …
Who is the assignee on this patent?
Relievant Medsystems Inc
What technology area does this patent fall under?
Primary CPC classification A61B17/1642. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).